GB0326759D0 - Pharmaceutical formulations and their preparation and use - Google Patents

Pharmaceutical formulations and their preparation and use

Info

Publication number
GB0326759D0
GB0326759D0 GB0326759A GB0326759A GB0326759D0 GB 0326759 D0 GB0326759 D0 GB 0326759D0 GB 0326759 A GB0326759 A GB 0326759A GB 0326759 A GB0326759 A GB 0326759A GB 0326759 D0 GB0326759 D0 GB 0326759D0
Authority
GB
United Kingdom
Prior art keywords
preparation
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0326759A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Het Nederlands Kanker Instituut
Original Assignee
Het Nederlands Kanker Instituut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Het Nederlands Kanker Instituut filed Critical Het Nederlands Kanker Instituut
Priority to GB0326759A priority Critical patent/GB0326759D0/en
Publication of GB0326759D0 publication Critical patent/GB0326759D0/en
Priority to DE602004021713T priority patent/DE602004021713D1/en
Priority to EP04798989A priority patent/EP1686959B1/en
Priority to ES04798989T priority patent/ES2329374T3/en
Priority to AT04798989T priority patent/ATE434431T1/en
Priority to US10/579,230 priority patent/US7915227B2/en
Priority to PCT/IB2004/003886 priority patent/WO2005046637A2/en
Priority to US13/038,655 priority patent/US20110150984A1/en
Ceased legal-status Critical Current

Links

GB0326759A 2003-11-14 2003-11-17 Pharmaceutical formulations and their preparation and use Ceased GB0326759D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GB0326759A GB0326759D0 (en) 2003-11-17 2003-11-17 Pharmaceutical formulations and their preparation and use
DE602004021713T DE602004021713D1 (en) 2003-11-14 2004-11-11 Pharmaceutical Formulations with Short Chain Sphingolipids and Their Use
EP04798989A EP1686959B1 (en) 2003-11-14 2004-11-11 Pharmaceutical formulations employing short-chain sphingolipids and their use
ES04798989T ES2329374T3 (en) 2003-11-14 2004-11-11 PHARMACEUTICAL FORMULATIONS THAT USE SHORT CHAIN SPHYNOLIPIDS AND USES OF THE SAME.
AT04798989T ATE434431T1 (en) 2003-11-14 2004-11-11 PHARMACEUTICAL FORMULATIONS CONTAINING SHORT CHAIN SPHINGOLIPIDS AND USE THEREOF
US10/579,230 US7915227B2 (en) 2003-11-14 2004-11-11 Pharmaceutical formulations employing short-chain sphingolipids and their use
PCT/IB2004/003886 WO2005046637A2 (en) 2003-11-14 2004-11-11 Pharmaceutical formulations employing short-chain sphingolipids and their use
US13/038,655 US20110150984A1 (en) 2003-11-14 2011-03-02 Methods of increasing the bioavailability and/or cellular update of drugs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0326759A GB0326759D0 (en) 2003-11-17 2003-11-17 Pharmaceutical formulations and their preparation and use

Publications (1)

Publication Number Publication Date
GB0326759D0 true GB0326759D0 (en) 2003-12-17

Family

ID=29726703

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0326759A Ceased GB0326759D0 (en) 2003-11-14 2003-11-17 Pharmaceutical formulations and their preparation and use

Country Status (1)

Country Link
GB (1) GB0326759D0 (en)

Similar Documents

Publication Publication Date Title
TWI319319B (en) New solid pharmaceutical formulations comprising telmisartan and preparation thereof
HK1164133A1 (en) Nasal pharmaceutical formulations and methods of using the same
IL173808A0 (en) Pharmaceutical liposomal formulations
IL176248A0 (en) N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
IL172824A0 (en) Pharmaceutical formulations
GB0210397D0 (en) Pharmaceutical formulations
GB0302671D0 (en) Pharmaceutical formulations
HK1084883A1 (en) 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof
IL170758A0 (en) 7-amino-isoindolyl compounds and their pharmaceutical uses
IL173726A (en) Pharmaceutical compositions comprising n-n-dihaloamino acid and uses thereof
HK1091727A1 (en) Nasal pharmaceutical formulations and methods of using the same
IL170313A (en) Diarylcycloalkyl derivatives and pharmaceutical compositions comprising them
IL176384A (en) Fused pyrrolidinocarbazoles and pharmaceutical compositions comprising them
GB0108470D0 (en) Pharmaceutical compositions and their use
GB2392093B (en) Pharmaceutical formulations
GB0316206D0 (en) Pharmaceutical formulation
GB0302672D0 (en) Pharmaceutical formulations
IL175746A0 (en) Oral formulations of desoxypeganine and uses thereof
GB0316341D0 (en) Pharmaceutical formulations
IL172096A0 (en) Pharmaceutical formulations comprising amoxicillin and clavulanate
GB0317877D0 (en) Pharmaceutical combinations and formulations with improved stability
GB0326759D0 (en) Pharmaceutical formulations and their preparation and use
GB0309509D0 (en) Pharmaceutical compositions and their uses
GB0308317D0 (en) Pharmaceutical preparations and their use
GB0316335D0 (en) Pharmaceutical formulations

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)